Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome

American Journal on Intellectual and Developmental Disabilities

Volumn 115, Issue 2, 2010, Pages 83-112

  Rachidi, Mohammed ^a   Lopes, Carmela ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF FRENCH POLYNESIA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; COGNITIVE DEFECT; DISEASE MODEL; DOWN SYNDROME; GENETICS; GENOMICS; HUMAN; MENTAL DEFICIENCY; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PROTEOMICS; REVIEW;

ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOWN SYNDROME; GENOMICS; HUMANS; MENTAL RETARDATION; MICE; PROTEOMICS;

EID: 77952752313     PISSN: 19447558     EISSN: None     Source Type: Journal    
DOI: 10.1352/1944-7558-115.2.83     Document Type: Article

References (226)

1. Abbeduto, L., Warren, S. F., & Conners, F.A. (2007). Language development in Down syndrome: From the prelinguistic period to the acquisition of literacy. Mental Retardation and Developmental Disabilities Research Reviews, 13, 247-261. (Pubitemid 47613279)
2. Ahn, K. J., Jeong, H. K., Choi, H. S., Ryoo, S. R., Kim, Y. J., Goo, J. S., et al. (2006). DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiology of Disease, 22, 463-472. (Pubitemid 43832120)
3. Aït Ahn-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., et al. (2007). Classification of human chromosome 21 gene-expression variations in Down syndrome: Impact on disease phenotypes. America Journal of Human Genetics, 81, 475-491. (Pubitemid 47330207)
4. Aldridge, K., Reeves, R. H., Olson, L. E., & Richtsmeier, J. T. (2007). Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. American Journal of Medical Genetics, 143A, 1060-1070. (Pubitemid 46709276)
5. Altafaj, X., Dierssen, M., Baamonde, C., Marti, E, Visa, J, Guimera, J., et al. (2001). Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Human Molecular Genetics, 10, 1915-1923. (Pubitemid 32910536)
6. Amano, K., Sago, H., Uchikawa, C., Suzuki, T., Kotliarova, S. E., Nukina, N., et al. (2004). Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Human Molecular Genetics, 13, 1333-1340. (Pubitemid 38967186)
7. Antonarakis, S. E. (2001). Chromosome 21: From sequence to applications. Current Opinion in Genetics and Development, 11, 241-246. (Pubitemid 32480288)
8. Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004). Chromosome 21 and Down syndrome: From genomics to pathophysiology. Nature Reviews Genetics, 5, 725-738. (Pubitemid 39336357)
9. Arai, Y., Ijuin, T., Takenawa, T., Becker, L. E., & Takashima, S. (2002). Excessive expression of synaptojanin in brains with Down syndrome. Brain and Development, 24, 67-72. (Pubitemid 34224905)
10. Arron, J. R., Winslow, M. M., Polleri, A., Chang, C. P., Wu, H., Gao, X., et al. (2006). NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature, 441, 595-600. (Pubitemid 43927286)
11. Aylward, E. H., Habbak, R., Warren, A. C., Pulsifer, M. B., Barta, P. E., Jerram, M., & Pearlson, G. D. (1997). Cerebellar volume in adults with Down syndrome. Archives of Neurology, 54, 209-212. (Pubitemid 27078729)
12. Bahn, S., Mimmack, M., Ryan, M., Caldwell, M. A., Jauniaux, E., Starkey, M., & Svendsen, C. N. (2002). Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: A gene expression study. Lancet, 359, 310-315. (Pubitemid 34119295)
13. Balcz, B., Kirchner, L., Cairns, N., Fountoulakis, M., & Lubec, G. (2001). Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease. Journal of Neural Transmission Supplementum, 61, 193-201. (Pubitemid 38085082)
14. Baxter, L. L., Moran, T. H., Richtsmeier, J. T., Troncoso, J., & Reeves, R. H. (2000). Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Human Molecular Genetics, 9, 195-202. (Pubitemid 30052743)
15. Becker, L. E., Armstrong, D. L., & Chan, F. (1986). Dendritic atrophy in children with Down's syndrome. Annals of Neurology, 20, 520-532.
16. Becker, L., Mito, T., Takashima, S., & Onodera, K. (1991). Growth and development of the brain in Down syndrome. In C. H. Epstein (Ed.), The morphogenesis of Down syndrome (pp. 133-152). New York: Wiley-Liss.
17. Belichenko, N. P., Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Reeves, R. H., & Mobley, W. C. (2009). The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. Journal of Neuroscience, 29, 5938-5948.
18. Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., et al. (2004). Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome. Journal of Comparative Neurology, 480, 281-298. (Pubitemid 39578025)
19. Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Epstein, C. J., & Mobley, W. C. (2007). Synaptic and cognitive abnormalities in mouse models of Down syndrome: Exploring genotype-phenotype relationships. Journal of Comparative Neurology, 504, 329-345. (Pubitemid 47437199)
20. Benavides-Piccione, R., Ballesteros-Yanez, I., Martinez de Lagran, M., Elston, G., Estivill, X., Fillat, C., et al. (2004). On dendrites in Down syndrome and Down syndrome murine models: A spiny way to learn. Progress in Neurobiology, 74, 111-126. (Pubitemid 39423861)
21. Benavides-Piccione, R., Dierssen, M., Ballesteros-Yaöez, I., Martinez de Lagran, M., Arbones, M. L., Fotaki, V., et al. (2005). Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A +/2 mouse. Neurobiology of Disease, 20, 115-122. (Pubitemid 41219208)
22. Berto, G., Camera, P., Fusco, C., Imarisio, S., Ambrogio, C., Chiarle, R., et al. (2007). The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase. Journal of Cell Science, 120, 1859-1867. (Pubitemid 46979777)
23. Best, T. K., Siarey, R. J., & Galdzicki, Z. (2006). Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB induced potassium current. Journal of Neurophysiology, 97, 892-900.
24. Black, A. H., Nadel, L., & O'Keefe, J. (1977). Hippocampal function in avoidance learning and punishment. Psychological Bulletin, 84, 1107-1129.
25. Blednow, Y. A., Stoffel, M., Chang, S. R., & Harris, R. A. (2001). GIRK2 deficient mice: Evidence for hyperactivity and reduced anxiety. Physiology and Behavior, 74, 109-117. (Pubitemid 32879367)
26. Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G., & Silva, A. J. (1994). Deficient long-term memory in mice with a targeted mutation of the Campresponsive element-binding protein. Cell, 79, 59-68.
27. Branchi, I., Bichler, Z., Minghetti, L., Delabar, J. M., Malchiodi-Albedi, F., Gonzalez, M. C., et al. (2004). Transgenic mouse in vivo library of human Down syndrome Critical Region 1: Association between DYRK1A overexpansion, brain development abnormalities, and cell cycle protein alteration. Journal of Neuropathology and Experimental Neurology, 63, 429-440. (Pubitemid 38669664)
28. Brown, F. R., Greer, M. K., Aylward, E. H., & Hunt, H. H. (1990). Intellectual and adaptive functioning in individuals with Down syndrome in relation to age and environmental placement. Pediatrics, 85, 450-452. (Pubitemid 20070826)
29. Brown, J. H., Johnson, M. H., Patterson, S. J., Gilmore, R., Longhi, E., & Karmiloff-Smith, A. (2003). Spatial representation and attention in toddlers with Wil liams syndrome and Down syndrome. Neuropsychologia, 41, 1037-1046. (Pubitemid 36349395)
30. Bushati, N., & Cohen, S. M. (2007). microRNA functions. Annual Review of Cell and Developmental Biology, 3, 175-205.
31. Carlesimo, G. A., Marotta, L., & Vicari, S. (1997). Long-term memory in mental retardation: Evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia, 35, 71-79. (Pubitemid 26418235)
32. Casanova, M. F., Walker, L. C., Whitehouse, P. J., & Price, D. L. (1985). Abnormalities of the nucleus basalis in Down's syndrome. Annals of Neurology, 18, 310-313. (Pubitemid 15023103)
33. Cavailles, V., Dauvois, S., L'Horset, F., Lopes, G., Hoare, S., Kushner, P. J., & Parker, M. G. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO Journal, 14, 3741-3751.
34. Chabert, C., Jamon, M., Cherfouh, A., Duquenne, V., Smith, D. J., Rubin, E., & Roubertoux, P. L. (2004). Functional analysis of genes implicated in Down syndrome: 1. Cognitive abilities in mice transpolygenic for Down syndrome chromosomal region-1 (DCR-1). Behavior Genetics, 34, 559-569. (Pubitemid 39463125)
35. Chakrabarti, L., Galdzicki, Z., & Haydar, T. F. (2007). Defects in embryonic neurogenesis and initial synapse formation in the forebrain in the Ts65Dn mouse model of Down syndrome. Journal of Neuroscience, 27, 11483-11495. (Pubitemid 350006912)
36. Chapman, R. S., & Hesketh, L. J. (2000). Behavioral phenotype of individuals with Down syndrome. Mental Retardation and Developmental Disabilities Research Reviews, 6, 84-95. (Pubitemid 30399531)
37. Chapman, R. S., Seung, H. K., Schwartz, S. E., & Kay-Raining Bird, E. (1998). Language skills of children and adolescents with Down syndrome: II. Production deficits. Journal of Speech, Language, & Hearing Research, 41, 861-873. (Pubitemid 28357805)
38. Chen, B. E., Kondo, M., Garnier, A., Watson, F. L., Puettmann-Holgado, R., Lamar, D. R., & Schmucker, D. (2006). The molecular diversity of Dscam is functionally required for neuronal wiring specificity in Drosophila. Cell, 125, 607-620.
39. Cheon, M. S., Bajo, M., Kim, S. H., Claudio, J. O., Stewart, A. K., Patterson, D., (2003). Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part II). Amino Acids, 24, 119-125. (Pubitemid 36407954)
40. Cheon, M. S., Fountoulakis, M., Dierssen, M., Ferreres, J. C., & Lubec, G. (2001). Expression profiles of proteins in fetal brain with Down syndrome. Journal of Neural Transmission Supplementum, 61, 311-319. (Pubitemid 38085093)
41. Cheon, M. S., Kim, S. H., Ovod, V., Kopitar Jerala, N., Morgan, J I., Hatefi, Y., et al. (2003). Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part III). Amino Acids, 24, 127-134. (Pubitemid 36407955)
42. Cheon, M. S., Kim, S. H., Yaspo, M. L., Blasi, F., Aoki, Y., Melen, K., & Lubec, G. (2003). Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part I). Amino Acids, 24, 111-117. (Pubitemid 36407953)
43. Cheon, M. S., Shim, K. S., Kim, S. H., Hara, A., & Lubec, G. (2003). Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV). Amino Acids, 25, 41-47. (Pubitemid 36930211)
44. Chou, C. Y., Liu, L. Y., Chen, C. Y., Tsai, C. H., Hwa, H. L., Chang, L. Y., et al. (2008). Gene expression variation increase in trisomy 21 tissues. Mammalian Genome, 19, 398-405.
45. Chrast, R., Scott, H. S., Papasavvas, M. P., Rossier, C., Antonarakis, E. S., Barras, C., et al. (2000). The mouse brain transcriptome by SAGE: Differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Research, 10, 2006-2021. (Pubitemid 32049145)
46. Clark, D., & Wilson, G. N. (2003). Behavioral assessment of children with Down syndrome using the Reiss psychopathology scale. American Journal of Medical Genetics Part A, 118, 210-216. (Pubitemid 37063928)
47. Costa, A. C. S., & Grybko, M. J. (2005). Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome. Neuroscience Letters, 382, 317-322. (Pubitemid 40733644)
48. Costa, A. C. S., Scott-McKean, J. J., & Stasko, M. R. (2008). Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a conditioning fear test. Neuropsychopharmacology, 33, 1624-1632. (Pubitemid 351684704)
49. Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986). The neurobiologic consequences of Down syndrome. Brain Research Bulletin, 16, 773-787. (Pubitemid 16041613)
50. Crabtree, G. R., & Olson, E. N. (2002). NFAT signalling: Choreagraphing the social lives of cells. Cell, 109(Suppl.), S67-S79. (Pubitemid 34457853)
51. Cremona, O., Di Paolo, G., Wenk, M. R., Luthi, A., Kim, W. T., Takei, K., et al. (1999). Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell, 99, 179-188. (Pubitemid 29491784)
52. Das, A. K., Cohen, P. W., & Barford, D. (1998). The structure of the tetratricopeptide repeats of protein phosphatase 5: Implications for TPR-mediated protein-protein interactions. EMBO Journal, 17, 1192-1199. (Pubitemid 28105498)
53. Dauphinot, L., Lyle, R., Rivals, I., Dang, M. T., Moldrich, R. X., Golfier, G., et al. (2005). The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Human Molecular Genetics, 14, 373-384. (Pubitemid 40220654)
54. Davisson, M. T., Schmidt, C., & Akeson, E. C. (1990). Segmental trisomy of murine chromosome 16: A new model system for studying Down syndrome. Progress in Clinical and Biological Research, 360, 263-280.
55. Delabar, J. M., Theophile, D., Rahmani, Z., Chettouh, Z., Blouin, J. L., Prieur, M., et al. (1993). Molecular mapping of twenty-four features of Down syndrome on chromosome 21. European Journal of Human Genetics, 1, 114-124.
56. Deutsch, S., Lyle, R., Dermitzakis, E. T., Attar, H., Subrahmanyan, L., Gehrig, C., et al. (2005). Gene expression variation and expression quantitative trait mapping of human chromosome 21 genes. Human Molecular Genetics, 14, 3741-3749. (Pubitemid 41754672)
57. Dierssen, M., & Ramakers, G. J. A. (2006). Dendritic pathology in mental retardation; from molecular genetics to neurobiology. Genes, Brain and Behavior, 5(Suppl. 2), 48-60.
58. Dierssen, M., Vallina, I. F., Baamonde, C., Garcia- Calatayud, S., & Lumbreras, M. A. (1997). Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome. Brain Research, 749, 238-244. (Pubitemid 27104205)
59. Dierssen, M., Vallina, I. F., Baamonde, C., Lumbreras, M. A., Martinez-Cue, C., Calatayud, S. G., & Florez, J. (1996). Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model. Developmental Brain Research, 95, 122-124. (Pubitemid 26259829)
60. Engidawork, E., Balic, N., Fountoulakis, M., Dierssen, M., Graber-Platzer, S., & Lubec, G. (2001). b-Amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: Further evidence against gene dosage effect. Journal of Neural Transmission Supplementum, 61, 335-346. (Pubitemid 38085095)
61. Engidawork, E., Gulesserian, T., Balic, N., Cairns, N., & Lubec, G. (2001). Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease. Journal of Neural Transmission Supplementum, 61, 211-222. (Pubitemid 38085084)
62. Engidawork, E., & Lubec, G. (2003). Molecular changes in fetal Down syndrome brain. Journal of Neurochemistry, 84, 895-904. (Pubitemid 36330644)
63. Epstein, C. J. (1986). The consequences of chromosome imbalance: Principles, mechanisms, and models. New York: Cambridge University Press.
64. Epstein, C. J. (1988). Mechanisms of the effects of aneuploidy in mammals. Annual Review of Genetics, 22, 51-75. (Pubitemid 19156665)
65. Epstein, C. J. (1990). The consequences of chromosome imbalance. American Journal of Human Genetics, 7(Suppl.), 31-37.
66. Epstein, J. (2001). Down syndrome. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (7th ed., pp. 1223-1256). New York: McGraw-Hill.
67. Epstein, C. J., Avraham, K. B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., et al. (1987). Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proceedings of the National Academy of Sciences, 84, 8044-8048.
68. Epstein, C. J., Hofmeister, B. G., Yee, D., Smith, S. A., Philip, R., Cox, D. R., & Epstein, L. B. (1985). Stem cell deficiencies and thymic abnormalities in fetal mouse trisomy 16. Journal of Experimental Medicine, 162, 695-712. (Pubitemid 15249969)
69. Ermak, G., Morgan, T. E., & Davies, K. J. (2001). Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. Journal of Biological Chemistry, 276, 38787-38794.
70. Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007). Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nature Neuroscience, 10, 411-413. (Pubitemid 46494581)
71. Ferrando-Miguel, R., Cheon, M. S., & Lubec, G. (2004). Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain (Part V); Overexpression of phosphati- dyl-inositol-glycan class P protein (DSCR5). Amino Acids, 26, 255-261. (Pubitemid 38829788)
72. FitzPatrick, D. R., Ramsay, J., McGill, N. I., Shade, M., Carothers, A. D., & Hastie, N. D. (2002). Transcriptome analysis of human autosomal trisomy. Human Molecular Genetics, 11, 3249-3256. (Pubitemid 36054653)
73. Fotaki, V., Dierssen, M., Alcantara, S., Martinez, S., Marti, E., Casas, C., et al. (2002). Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Molecular and Cellular Biology, 22, 6636-6647.
74. Freidl, M., Gulesserian, T., Lubec, G., Fountoulakis, M., & Lubec, B. (2001). Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down syndrome. Journal of Neural Transmission, Supplementum, 61, 47-57. (Pubitemid 38085071)
75. Fuentes, J. J., Genesca, L., Kingsbury, T. J., Cunningham, K. W., Perez-Riba, M., Estivill, X., & de la Luna, S. (2000). DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Human Molecular Genetics, 9, 1681-1690. (Pubitemid 30427005)
76. Funahashi, S., Takeda, K., & Watanabe, Y. (2004). Neural mechanisms of spatial working memory: Contributions of the dorsolateral prefrontal cortex and the thalamic mediodorsal nucleus. Cognitive, Affective and Behavioral Neuroscience, 4, 409-420. (Pubitemid 40342890)
77. Galante, M., Jani, H., Vanes, L., Daniel, H., Fisher, E. M., Tybulewicz, V. L., et al. (2009). Impairments in motor coordination without major changes in cerebellar plasticity in the Tc1 mouse model of Down syndrome. Human Molecular Genetics, 18, 1449-1463.
78. Gardiner, K. (2003). Predicting pathway perturbation in Down syndrome. Journal of Neural Transmission, 67(Suppl.), 21-37. (Pubitemid 38344136)
79. Gardiner, K. (2006). Transcriptional dysregulation in Down syndrome: Predictions for altered protein complex stoichiometries and posttranslational modifications, and consequences for learning/behaviour genes ELK, CREB, and the estrogen and glucocorticoid receptors. Behavior Genetics, 36, 439-453. (Pubitemid 43876782)
80. Gardiner, K., Davisson, M. T., & Crnic, L. S. (2004). Building protein interaction maps for Down's syndrome. Briefings in Functional Genomics and Proteomics, 3, 142-156.
81. Gardiner, K., Fortna, A., Bechtel, L., & Davisson, M. T. (2003). Mouse models of Down syndrome: How useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene, 318, 137-147. (Pubitemid 37338399)
82. Gearhart, J. D., Davisson, M. T., & Oster-Granite, M. L. (1986). Autosomal aneuploidy in mice: Generation and developmental consequences. Brain Research Bulletin, 16, 789-801. (Pubitemid 16041614)
83. Golden, J. A., & Hyman, B. T. (1994). Development of the superior temporal neocortex is anomalous in trisomy 21. Journal of Neuropathology and Experimental Neurology, 53, 513-552.
84. Goldowitz, D., & Smeyne, R. J. (1995). Tune into the weaver channel. Nature Genetics, 11, 107-109.
85. Graef, I. A., Che, F., & Crabtree, G. R. (2001). NFAT signaling in vertebrate development. Current Opinion in Genetics and Development, 11, 505-512. (Pubitemid 32800723)
86. Granholm, A. C., Ford, K. A., Hyde, L. A., Bimonte, H. A., Hunter, C. L., Nelson, M., et al. (2002). Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Physiology and Behavior, 77, 371-385. (Pubitemid 35373893)
87. Greber-Platzer, S., Schatzmann-Turhani, D., Cairns, N., Balcz, B., & Lubec, G. (1999). Expression of the transcription factor ETS2 in brain of patients with Down syndrome- Evidence against the overexpression-gene dosage hypothesis. Journal of Neural Transmission, 57(Suppl.), 269-281.
88. Griffin, W. S. T., Sheng, J. G., McKenzie, L. E., Royston, M. C., Gentleman, S. M., Brumback, R. A., et al. (1998). Life-long overexpression of S100beta in Down's syndrome: Implications for Alzheimer pathogenesis. Neurobiology of Aging, 19, 401-405. (Pubitemid 29065489)
89. Guedj, F., Sébrié, C., Rivals, I., Ledru, A., Paly, E., Bizot, J. C., et al. (2009). Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS One, 4, e4606.
90. Gwack, Y., Sharma, S., Nardone, J., Tanasa, B., Iuga, A., Srikanth, S., et al. (2006). A genomewide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature, 441, 646-650. (Pubitemid 43927297)
91. Haffner, C., Takei, K., Chen, H., Ringstad, N., Hudson, A., Butler, M. H., et al. (1997). Synaptojanin 1: Localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15. FEBS Letters, 419, 175-180. (Pubitemid 28010805)
92. Hammerle, B., Carnicero, A., Elizalde, C., Ceron, J., Martinez, S., & Tejedor, F. J. (2003). Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation. European Journal of Neuroscience, 17, 2277-2286. (Pubitemid 36793737)
93. Hanson, J. E., Blank, M., Valenzuela, R. A., Garner, C. C., & Madison, D. V. (2007). The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Downs's syndrome. Journal of Physiology, 579, 53-67.
94. Harashima, C., Jacobowitz, D. M., Stoffel, M., Chakrabarti, L., Haydar, T. F., Siarey, R. J., & Galdzicki, Z. (2006). Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model. Cellular and Molecular Neurobiology, 26, 719-734.
95. Harashima, C., Jacobowitz, D. M., Witta, J., Borke, R. C., Best, T. K., Siarev, R. J., & Galdzicki, Z. (2006). Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: A model of Down syndrome. Journal ofComparativeNeurology, 494, 815-833. (Pubitemid 43054228)
96. Harris-Cerruti, C., Kamsler, A., Kaplan, B., Lamb, B., Segal, M., & Groner, Y. (2004). Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein. European Journal of Neuroscience, 19, 1174-1190. (Pubitemid 38387195)
97. Hattori, D., Demir, E., Kim, H. W., Viragh, E., Zipursky, S. L., & Dickson, B. J. (2007). Dscam diversity is essential for neuronal wiring and self-recognition. Nature, 449, 223-227. (Pubitemid 47402366)
98. Hattori, M., Fujiyama, A., Taylor, T. D., Watanabe, H., Yada, T., Park, H. S., et al. (2000). The DNA sequence of human chromosome 21. Nature, 405, 311-319. (Pubitemid 30337057)
99. Hennequin, M., Morin, C., & Feine, J. S. (2000). Pain expression and stimulus localisation in individuals with Down's syndrome. Lancet, 356, 1882-1887.
100. Hodapp, R. M., Ewans, D. E., & Gray, F. L. (1999). Intellectual development in children with Down syndrome. In J. A. Rondal, J. Perera, & L. Nadel (Eds.), Down syndrome: A review of current knowledge (pp. 124-132). London: Whurr.
101. Hoeffer, C. A., Dey, A., Sachan, N., Wong, H., Patterson, R. J., Shelton, J. M., et al. (2007). The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. Journal of Neuroscience, 27, 13161-13172. (Pubitemid 350220501)
102. Hulme, C., & Mackenzie, S. (1992). Working memory and severe learning difficulties. Hove, UK: Erlbaum.
103. Hunter, C. L., Isacson, O., Nelson, M., Bimonte- Nelson, H., Seo, H., Lin, L., et al. (2003). Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Neuroscience Research, 45, 437-445. (Pubitemid 36355843)
104. Huttenlocher, P. R. (1974). Dendritic development in neocortex of children with mental defect and infantile spasms. Neurology, 24, 203-210.
105. Ikegami, S., & Inokuchi, K. (2000). Antisense DNA against calcineurin facilitates memory in contextual fear conditioning by lowering the threshold for hippocampal long-term potentiation induction. Neuroscience, 98, 637-646. (Pubitemid 30417580)
106. International Human Genome Sequencing Consortium. (2004). Finishing the euchromatic sequence of the human genome. Nature, 431, 931-945.
107. Janus, C. (2004). Search strategies used by APP transgenic mice during navigation in the Morris water maze. Learning and Memory, 11, 337-346. (Pubitemid 38697900)
108. Joseph, R. M., & Tager-Flusberg, H. (1997). An investigation of attention and affect in children with autism and Down syndrome. Journal of Autism and Developmental Disorders, 27, 385-396. (Pubitemid 27319209)
109. Kadota, M., Nishigaki, R., Wang, C. C., Toda, T., Shirayoshi, Y., Inoue, T., et al. (2004). Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: An in vitro model of Down syndrome. Neuroscience, 129, 325-335. (Pubitemid 39388852)
110. Kahlem, P., Sultan, M., Herwig, R., Steinfath, M., Balzereit, D., Eppens, B., et al. (2004). Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome. Genome Research, 14, 1258-1267. (Pubitemid 39029222)
111. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., et al. (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733-736. (Pubitemid 17054046)
112. Kapranov, P., Cawley, S. E., Drenkow, J., Bekiranov, S., Strausberg, R. L., Fodor, S. P., & Fingeras, T. R. (2002). Large-scale transcriptional activity in chromosomes 21 and 22. Science, 296, 916-919. (Pubitemid 34464898)
113. Kentrup, H., Becker, W., Heukelbach, J., Wilmes, A., & Schurmann, A., et al. (1996). Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. Journal of Biological Chemistry, 271, 3488-3495. (Pubitemid 26065657)
114. Kim, S. H., & Lubec, G. (2001). Decreased alpha-endosulfine, an endogenous regulator of ATP-sensitive potassium channels, in brains from adult Down syndrome patients. Journal of Neural Transmission, Supplementum, 61, 1-9. (Pubitemid 38085068)
115. Kim, W. T., Chang, S., Daniell, L., Cremona, O., Di Paolo, G., & De Camilli, P. (2002). Delayed reentry of recycling vesicles into the fusion-competent synaptic vesicle pool in synaptojanin 1 knockout mice. Proceedings of the National Academy of Sciences, 99, 17143-17148. (Pubitemid 36034112)
116. Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004). Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. Journal of Neuroscience, 24, 8153-8160. (Pubitemid 39280835)
117. Korenberg, J. R., Chen, X. N., Schipper, R., Sun, Z., Gonsky, R., Gerwehr, S., et al. (1994). Down syndrome phenotypes: The consequences of chromosomal imbalance. Proceedings of the National Academy of Sciences, 91, 4997-5001. (Pubitemid 24177778)
118. Korenberg, J. R., Kawashima, H., Pulst, S. M., Ikeuchi, T., Ogasawara, N., Yamamoto, K., et al. (1990). Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. American Journal of Human Genetics, 47, 236-246.
119. Kuhn, D. E., Nuovo, G. J., Martin, M. M., Malana, G. E., Pleister, A. P., Jiang, J., et al. (2008). Human chromosome 21-derived miRNAs are overexpressed in Down syndrome brains and hearts. Biochemical and Biophysical Research Communications, 370, 473-477.
120. Kurnit, D. M. (1979). Down syndrome: Gene dosage at the transcriptional level in skin fibroblasts. Proceedings of the National Academy of Sciences, 76, 2372-2375. (Pubitemid 9184931)
121. Kurt, M. A., Davies, D. C., Kidd, M., Dierssen, M., & Florez, J. (2000). Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Research, 858, 191-197. (Pubitemid 30105799)
122. Kurt, M. A., Kafa, I. M., Dierssen, M., & Davies, C. D. (2004). Deficits of neuronal density in CA1 and synaptic density in the Kurt dentat gyrus, CA3 and CA1, in a mouse model of Down syndrome. Brain Research, 1022, 101-109. (Pubitemid 39194990)
123. Lamb, B. T., Sisodia, S. S., Lawler, A. M., Slunt, H. H., Kitt, C. A., Kearns, W. G., et al. (1993). Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nature Genetics, 5, 22-30. (Pubitemid 23261513)
124. Larsen, K. B., Laursen, H., Graem, N., Samuelsen, G. B., Bogdanovic, N., & Pakkenberg, B. (2008). Reduced cell number in the neocortical part of the human fetal brain in Down syndrome. Annals of Anatomy, 190, 421-427.
125. Lejeune, J. (1990). Pathogenesis of mental deficiency in trisomy 21. American Journal of Medical Genetics, 7(Suppl.), 20-30.
126. Lejeune, J., Gautier, M., & Turpin, R. (1959). Etude des chromosomes somatiques de neufs enfants Mongoliens. Comptes Rendu de l'Acade 'mie des Sciences de Paris, 248, 1721-1722.
127. Le Pecheur, M., Bourdon, E., Paly, E., Farout, L., Friguet, B., & London, J. (2005). Oxidized SOD1 alters proteasome activities in vitro and in the cortex of SOD1 overexpressing mice. FEBS Letters, 579, 3613-3618. (Pubitemid 40897700)
128. Lesage, G., Duprat, F., Fink, M., Guillermare, E., Coppola, T., Lazdunski, M., & Hugnot, J. P. (1994). Cloning provides evidence for a family of inward rectifier and G-protein coupled K+ channels in the brain. FEBS Letters, 353, 37-42.
129. Lieberman, D. N., & Mody, I. (1994). Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. Nature, 369, 235-239. (Pubitemid 24154801)
130. Ly, A., Nikolaev, A., Suresh, G., Zheng, Y., Tessier-Lavigne, M., & Stein, E. (2008). DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1. Cell, 133, 1241-1254. (Pubitemid 351852917)
131. Lyle, R., Gehrig, C., Neergaard-Henrichsen, C., Deutsch, S., & Antonarakis, S. E. (2004). Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Research, 14, 1268-1274. (Pubitemid 39029223)
132. Malleret, G., Haditsch, U., Genoux, D., Jones, M. W., Bliss, T. V., Vanhoose, A. M., et al. (2001). Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell, 104, 675-686. (Pubitemid 32241018)
133. Mansuy, I. M. (2003). Calcineurin in memory and bidirectional plasticity. Biochemical and Biophysical Research Communication, 311, 1195-1208. (Pubitemid 37393442)
134. Mansuy, I. M., Mayford, M., Jacob, B., Kandel, E. R., & Bach, M. E. (1998). Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell, 92, 39-49. (Pubitemid 28053296)
135. Mansuy, I. M., Winder, D. G., Moallem, T. M., Osman, M., Mayford, M.,
136. Mao, L., Zabel, C., Herrmann, M., Nolden, T., Mertes, F., Magnol, L., et al. (2007). Proteomic shifts in embryonic stem cells with gene dose modifications suggest the presence of balancer proteins in protein regulatory networks. PLoS One, 2, e1218.
137. Mao, R., Wang, X., Spitznagel, E. L., Jr., Frelin, L. P., Ting, J. C., Ding, H., et al. (2005). Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biology, 6, R107.
138. Mao, R., Zielke, C. L., Zielke, H. R., & Pevsner, J. (2003). Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics, 81, 457-467. (Pubitemid 36437522)
139. Marin-Padilla, M. (1972). Structural abnormalities of the cerebral cortex in human chromosomal aberrations: A Golgi study. Brain Research, 44, 625-629.
140. Marin-Padilla, M. (1976). Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. Journal of Comparative Neurology, 167, 63-75.
141. McPherson, P. S. (1999). Regulatory role of SH3 domain-mediated protein-protein interactions in synaptic vesicle endocytosis. Cell Signal, 11, 229-238. (Pubitemid 29185124)
142. McPherson, P. S., Takei, K., Schmid, S. L., & De Camilli, P. (1994). p145, a major Grb2- binding protein in brain, is co-localized with dynamin in nerve terminals where it undergoes activity-dependent dephosphorylation. Journal of Biological Chemistry, 269, 30132-30139. (Pubitemid 24376477)
143. Milner, B., Squire, L. R., & Kandel, E. R. (1998). Cognitive neuroscience and the study of memory. Neuron, 20, 445-468. (Pubitemid 28153077)
144. Morice, E., Andreae, L. C., Cooke, S. F., Vanes, L., Fisher, E. M., Tybulewicz, V. L., & Bliss, T. V. (2008). Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learning and Memory, 15, 492-500. (Pubitemid 352008671)
145. Mural, R. J., Adams, M. D., Myers, E. W., Smith, H. O., Miklos, G. L., Wildes, R., et al. (2002). A comparison of whole-genome shotgunderived mouse chromosome 16 and the human genome. Science, 296, 1661-1671. (Pubitemid 34579160)
146. Nadel, L. (2003). Down's syndrome: A genetic disorder in biobehavioral perspective. Genes, Brain and Behavior, 2, 156-166. (Pubitemid 36898802)
147. Nadel, L., & Willner, J., (1980). Context and conditioning: A place for space. Physiology and Psychology, 8, 218-228. (Pubitemid 11231166)
148. Nelson, L., Johnson, J. K., Freedman, M., Lott, I., Groot, J., Chang, M., et al. (2005). Learning and memory as a function of age in Down syndrome: A study using animal-based tasks. Progress in Neuropsychopharmacology and Biological Psychiatry, 29, 443-453. (Pubitemid 40417596)
149. Nikolaienko, O., Nguyen, C., Crinc, L. S., Cios, K. J., & Gardiner, K. (2005). Human chromosome 21/Down syndrome gene function and pathway database. Gene, 364, 90-98. (Pubitemid 41773238)
150. O'Doherty, A., Ruf, S., Mullingan, C., Hildreth, V., Errington, M. L., Cooke, S., et al. (2005). An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science, 309, 2033-2037. (Pubitemid 41362316)
151. Ohira, M., Seki, N., Nagase, T., Suzuki, E., Nomura, N., Ohara, O., et al. (1997). Gene identification in 1.6-Mb region of the Down syndrome region on chromosome 21. Genome Research, 7, 47-58. (Pubitemid 27095567)
152. Olson, L. E., Richtsmeier, J. T., Leszl, J., & Reeves, R. H. (2004). A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science, 306, 687-690. (Pubitemid 39440917)
153. Olson, L. E., Roper, R. J., Sengstaken, C. L., Peterson, E. A., Aquino, V., Galdzicki, Z., et al. (2007). Trisomy for the Down syndrome "critical region" is necessary but not sufficient for brain phenotypes of trisomic mice. Human Molecular Genetics, 16, 774-782. (Pubitemid 47061624)
154. Ortiz-Abalia, J., Sahun, I., Altafaj, X., Andreu, N., Estivill, X., Dierssen, M., & Fillat, C. (2008). Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome. American Journal of Human Genetics, 83, 479-488.
155. Patil, N., Cox, D. R., Bhat, D., Faham, M., Myers, R. M., & Peterson, A. S. (1995). A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nature Genetics, 11, 126-129.
156. Pennington, B. F., Moon, J., Edgin, J., Stedron, J., & Nadel, L. (2003). The neuropsychology of Down syndrome: Evidence for hippocampal dysfunction. Child Development, 74, 75-93. (Pubitemid 37244589)
157. Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G.T., & Reiss, A. L. (2001). Neuroanatomy of Down's syndrome: A high-resolution MRI study. American Journal of Psychiatry, 158, 1659-1665. (Pubitemid 32923659)
158. Potier, M. C., Rivals, I., Mercier, G., Ettwiller, L., Moldrich, R. X., Laffaire, J., et al. (2006). Transcriptional disruptions in Down syndrome: A case study in the Ts1Cje mouse cerebellum during post-natal development. Journal of Neurochemistry, 97(Suppl. 1), 1004-1009.
159. Prandini, P., Deutsch, S., Lyle, R., Gagnebin, M., Delucinge Vivier, C., Delorenzi, M., et al. (2007). Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. American Journal of Human Genetics, 81, 252-263. (Pubitemid 47236074)
160. Priller, C., Bauer, T., Mitteregger, G., Krebs, B., Kretzschmar, H. A., & Herms, J. (2006). Synapse formation and function is modulated by the amyloid precursor protein. Journal of Neuroscience, 26, 7212-7221.
161. Pritchard, M. A., & Kola, I. (1999). The gene dosage effect hypothesis versus the amplified development instability hypothesis in Down syndrome. Journal of Neural Transmission, 57(Suppl.), 293-303.
162. Pulsifer, M. B. (1996). The neuropsychology of mental retardation. Journal of International Neuropsychological Society, 2, 159-176. (Pubitemid 126448706)
163. Purpura, D. P. (1974). Dendritic spine dysgenesis and mental retardation. Science, 186, 1126-1128.
164. Rachidi, M., & Lopes, C. (2007). Mental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms. Neuroscience Research, 59, 349-369. (Pubitemid 350007811)
165. Rachidi, M., & Lopes, C. (2008). Mental retardation and associated neurological dysfunctions in Down syndrome: A consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. European Journal of Paediatric Neurology, 12, 168-182. (Pubitemid 351545848)
166. Rachidi, M., Lopes, C., Charron, G., Delezoide, A. L., Paly, E., Bloch, B., & Delabar, J. M. (2005). Spatial and temporal localization during embryonic and fetal human development of the transcription factor SIM2 in brain regions altered in Down syndrome. International Journal of Developmental Neuroscience, 23, 475-484. (Pubitemid 40981872)
167. Rachidi, M., Lopes, C., Costantine, M., & Delabar, J. M. (2005). C21orf5, a new member of dopey family involved in morphogenesis, could participate in neurological alterations and mental retardation in Down syndrome. DNA Research, 12, 203-210.
168. Rachidi, M., Lopes, C., Delezoide, A. L., & Delabar, J. M. (2006). C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome. Cytogenetic and Genome Research, 112, 16-22. (Pubitemid 41579451)
169. Rachidi, M., Lopes, C., Gassanova, S., Sinet, P. M., Vekemans, M., Attie, T., et al. (2000). Regional and cellular specificity of the expression of TPRD, the tetratricopeptide Down syndrome gene, during human embryonic development. Mechanisms of Development, 93, 189-193. (Pubitemid 30216511)
170. Rachidi, M., Lopes, C., Vayssettes, C., Smith, D. J., Rubin, E. M., & Delabar, J. M. (2007). New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1. Biochemical and Biophysical Research Communication, 364, 488-494. (Pubitemid 350030919)
171. Rahmani, Z., Blouin, J. L., Creau-Goldberg, N., Watkins, P. C., Mattei, J. F., Poissonnier, M., et al. (1989). Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proceedings of the National Academy of Sciences, 86, 5958-5962. (Pubitemid 19217567)
172. Raz, N., Torres, I. J., Briggs, S. D., Spencer, W. D., Thornton, A. E., Loken, W. J., et al. (1995). Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: Evidence from MRI morphometry. Neurology, 45, 356-366.
173. Reeves, R. H., & Garner, C. C. (2007). A year of unprecedented progress in Down syndrome basic research. Mental Retardation and Developmental Disabilities Research Reviews, 13, 215-220. (Pubitemid 47613275)
174. Risser, D., Lubec, G., Caims, N., & Herrera-Marschitz, M. (1997) Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome. Life Sciences, 60, 1231-1237. (Pubitemid 27191762)
175. Roper, R. J., Baxter, L. L., Saran, N. G., Klinedinst, D. K., Beachy, P. A., & Reeves, R. H. (2006). Defective cerebellar response to mitogenic Hedgehog signaling in Down syndrome mice. Proceedings of the National Academy of Sciences, 103, 1452-1456. (Pubitemid 43191186)
176. Rothermel, B., Vega, R. B., Yang, J., Wu, H., Bassel-Duby, R., & Williams, R. S. (2000). A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. Journal of Biological Chemistry, 275, 8719-8725. (Pubitemid 30180224)
177. Rueda, N., Florez, J., & Martinez-Cué, C. (2008). Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Neuroscience Letters, 433, 22-27.
178. Sago, H., Carlson, E. J., Smith, D. J., Kilbridge, J., Rubin, E. M., Mobley, W. C., et al. (1998). Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioural abnormalities. Proceedings of the National Academy of Sciences, 95, 6256-6261. (Pubitemid 28248999)
179. Sanna, B., Brandt, E. B., Kaiser, R. A., Pfluger, P., Witt, S. A., Kimball, T. R., et al. (2006). Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo. Proceedings of the National Academy of Sciences, 103, 7327-7332. (Pubitemid 43727832)
180. Saran, N. G., Pletcher, M. T., Natale, J. E., Cheng, Y., & Reeves, R. H. (2003). Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Human Molecular Genetics, 12, 2013-2019. (Pubitemid 37038810)
181. Schaer, M., & Eliez, S. (2007). From genes to brain: Understanding brain development in neurogenetic disorders using neuroimaging techniques. Child and Adolescent Psychiatric Clinics of North America, 16, 557-579. (Pubitemid 46880396)
182. Schneider, C., Risser, D., Kirchner, L., Kitzmuller, E., Cairns, N., Prast, H., et al. (1997). Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease. Neuroscience Letters, 222, 183-186. (Pubitemid 27079733)
183. Seabrook, G. R., Smith, D. W., Bowery, B. J., Easter, A., Reynolds, T., Fitzjohn, S. M., et al. (1999). Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology, 38, 349-359. (Pubitemid 29097718)
184. Sethupathy, P., Borel, C., Gagnebin, M., Grant, G. R., Deutsch, S., Elton, T. S., et al. (2007). Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 39 untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes. American Journal of Human Genetics, 81, 405-413. (Pubitemid 47236088)
185. Shapiro, B. L. (1983). Down syndrome-A disruption of homeostasis. American Journal of Medical Genetics, 14, 241-269.
186. Shapiro, B. L. (1997). Down syndrome critical regions? Human Genetics, 99, 421-423.
187. Shapiro, B. L., & Whither-Azmitia, P. M. (1997). Down syndrome critical regions? Human Genetics, 99, 421-423.
188. Shefner, J. M., Reaume, A. G., Flood, D. G., Scott, R. W., Kowall, N. W., Ferrante, R. J., et al. (1999). Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology, 53, 1239-1246. (Pubitemid 29480082)
189. Shin, J. H., Gulesserian, T., Verger, E., Delabar, J. M., & Lubec, G. (2006). Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down syndrome critical region. Journal of Proteome Research, 5, 44-53. (Pubitemid 43100796)
190. Shinoharaohara, T., Tomizuka, K., Miyabara, S., Takehara, S., Kazuki, Y, Inoue, J., et al. (2001). Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Human Molecular Genetics, 10, 1163-1175. (Pubitemid 32487539)
191. Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999). Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology, 38, 1917-1920. (Pubitemid 29509730)
192. Siarey, R. J., Stoll, S. I., Rapoport, S. I., & Galdzicki, Z. (1997). Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology, 36, 1549-1554. (Pubitemid 28085914)
193. Siarey, R. J., Villar, A. J., Epstein, C. J., & Galdzicki, Z. (2005). Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Neuropharmacology, 49, 122-128. (Pubitemid 40910022)
194. Siddiqui, A., Lacroix, T., Stasko, M. R., Scott- McKean, J. J., Costa, A. C., & Gardiner, K. J. (2008). Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801. Genes, Brain and Behavior, 7, 810-820.
195. Smith, D. J., Stevens, M. E., Sudanagunta, S. P., Bronson, R. T., Makhinson, M., Watabe, A. M., et al. (1997). Functional screening of 2Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nature Genetics, 16, 28-36. (Pubitemid 27198153)
196. Smith, D. J., Zhu, Y., Zhang, J., Cheng, J. F., & Rubin, E. M. (1995). Construction of a panel of transgenic mice containing a contiguous 2- Mb set of YAC/P1 clones from human chromosome 21q22.2. Genomics, 27, 425-434.
197. Stoel-Gammon, C. (2001). Down syndrome phonology: Developmental patterns and intervention strategies. Down's Syndrome, Research and Practice, 7, 90-100.
198. Stoll, C., Alembik, Y., Dott, B., & Roth, M. P. (1990). Epidemiology of Down syndrome in 118,265 consecutive births. American Journal of Medical Genetics, 7(Suppl), 79-83.
199. Stranger, B. E., Forrest, M. S., Clark, A. G., Minichiello, M. J., Deutsch S., Lyle, R., et al. (2005). Genome-wide associations of gene expression variation in humans. PLoS Genetics, 1, e78.
200. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Widerhold, K. H., Misti, C., Rothacher, S., et al. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proceedings of the National Academy of Sciences, 94, 13287-13292. (Pubitemid 27518514)
201. Subramaniam, N., Treuter, E., & Okret, S. (1999). Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids. Journal of Biological Chemistry, 274, 18121-18127.
202. Sultan, M., Piccini, I., Balzereit, D., Herwig, R., Saran, N. G., Lehrach, H., et al. (2007). Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biology, 8, R91.
203. Sweatt, J. D. (2004). Mitogen-activated protein kinases in synaptic plasticity and memory. Current Opinion in Neurobiology, 14, 311-317. (Pubitemid 38759861)
204. Takashima, S., Ieshima, A., Nakamura, H., & Becker, L. E. (1989). Dendrites, dementia and Down syndrome. Brain and Development, 11, 131-133.
205. Takashima, S., Iida, K., Mito, T., & Arima, M. (1994). Dendritic and histochemical development and aging in patients with Down's syndrome. Journal of Intellectual Disability Research, 38, 265-273. (Pubitemid 24168352)
206. Teipel, S. J., & Hampel, H. (2006). Neuroanatomy of Down syndrome in vivo: A model of preclinical Alzheimer's disease. Behavior Genetics, 36, 405-415. (Pubitemid 43876779)
207. Teipel, S. J., Schapiro, M. B., Alexander, G. E., Krasuski, J. S., Horwitz, B., Hoehne, C., et al. (2006). Relation of corpus callusum and hippocampal size to age in nondemented adults with Down's syndrome. American Journal of Psychiatry, 160, 1870-1878. (Pubitemid 41103323)
208. Tejedor, F., Zhu, X. M., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., et al. (1995). Minibrain: A new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron, 14, 287-301.
209. Teyssier, C., Belguise, K., Galtier, F., Cavailles, V., & Chalbos, D. (2003). Receptor-interacting protein 140 binds c-Jun and inhibits estradiolinduced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. Molecular Endocrinology, 17, 287-299. (Pubitemid 36183151)
210. Toyoda, A., Noguchi, H., Taylor, T. D., Ito, T., Pletcher, M. T., Sakaki, Y., et al. (2002). Comparative genomic sequence analysis of the human chromosome 21 Down syndrome critical region. Genome Research, 12, 1323-1332.
211. Vicari, S. (2004). Memory development and intellectual disabilities. Acta Paediatrica, 93(Suppl.), 60-63.
212. Vicari, S. (2006). Motor development and neuropsychological patterns in persons with trisomy 21. Behavioral Genetics, 36, 355-364. (Pubitemid 43876775)
213. Vuksic, M., Petanjek, Z., Rasin, M., & Kostovic, I. (2002). Perinatal growth of prefrontal layer III pyramidal in Down syndrome. Pediatric Neurology, 27, 36-38. (Pubitemid 34823589)
214. Voronov, S. V., Frere, S. G., Giovedi, S., Pollina, E. A., Borel, C., Zhang, H., et al. (2008). Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome. Proceedings of the National Academy of Sciences, 105, 9415-9420.
215. Wang, C. C., Kadota, M., Nishigaki, R., Kazuki, Y., Shirayoshi, Y., & Rogers, M. S. (2004). Molecular hierarchy in neurons differentiated from mouse ES cells containing a single human chromosome 21. Biochemical and Biophysical Research Communication, 314, 335-350. (Pubitemid 38084722)
216. Wang, Y., Stricker, H. M., Gou, D., & Liu, L. (2007). MicroRNA: Past and present. Frontiers in Bioscience, 12, 2316-2329.
217. Weitzdoerfer, R., Stolzlechner, D., Dierssen, M., Ferreres, J., Fountoulakis, M., & Lubec, G. (2001). Reduction of nucleoside diphosphate kinase B, Rab GDP-dissociation inhibitor beta and histidine triad nucleotidebinding protein in fetal Down syndrome brain. Journal of Neural Transmission, Supplementum, 61, 347-359. (Pubitemid 38085096)
218. Wiseman, F. K., Alford, K. A., Tybulewicz, V. L., & Fisher, E. M. (2009). Down syndrome- Recent progress and future prospects. Human Molecular Genetics, 18, R75-R83.
219. Wisniewski, K. E. (1990). Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. American Journal of Medical Genetics, 7, 274-281.
220. Wisniewski, K. E., & Bobinski, M. (1990). Hypothalamic abnormalities in Down syndrome. Progress in Clinical and Biological Research, 373, 153-167.
221. Wisniewski, K. E., & Schmidt-Sidor, B. (1989). Postnatal delay of myelin formation in brains from Down syndrome infants and children. Clinical Neuropathology, 8, 55-62. (Pubitemid 19169365)
222. Yang, E. J., Ahn, Y. S., & Chung, K. C. (2001). Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells. Journal of Biological Chemistry, 276, 39819-39824.
223. Yates, C. M., Simpson, J., Gordon, A., Maloney, A. F., Allison, Y., Ritchie, I. M., & Urquhart, A. (1983). Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimertype dementia and Down's syndrome. Brain Research, 28, 119-126. (Pubitemid 14202769)
224. Yu, Y., Chu, P. Y., Bowser, D. N., Keating, D. J., & Dubach, D. (2008). Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle trafficking abnormalities. Human Molecular Genetics, 17, 3281-3290.
225. Zang, D. W., Yang, Q., Wang, H. X., Egan, G., Lopes, E. C., & Cheema, S. S. (2004). Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. European Journal of Neuroscience, 20, 1745-1751. (Pubitemid 39471567)
226. Zeng, H., Chattarji, S., Barbarosie, M., Rondi- Reig, L., Philpot, B. D., Miyakawa, T., et al. (2001). Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell, 107, 617-629. (Pubitemid 34014863)